April marks the beginning of Oral & Head and Neck Cancer Awareness Month. This year, more than 50,000 new cases are expected to be diagnosed in the US. Specialists often refer to head and neck ...

Incidence of RTOME is 5.83 percent in patients with head and neck cancer, with significant variation seen by cancer type.

Being an advocate for your health. The head and neck are two of the most crucial parts of the body, and ensuring they are healthy is vital to living your best life. April is Head and Neck Cancer ...

Dr. Changxing Liu with Ascension St. John Medical Center outlines how Oklahomans can lower their risk of head and neck cancer with lifestyle changes and early care. “Head and neck cancer ...

The article titled "Neoadjuvant Leukocyte Interleukin Injection Immunotherapy Improves Overall Survival in Low-risk Locally Advanced Head and Neck Squamous Cell Carcinoma -The IT-MATTERS Study ...

Head and neck cancers, which are twice as prevalent in men compared to women and primarily affect individuals over the age of 50, represent approximately 4% of all cancer cases in the U.S.

Failures are an integral part of life's pursuits. Too often, we attribute our setbacks to external constraints — limited resources or opportunities, inadequate platforms, socio-cultural barriers ...

Please provide your email address to receive an email when new articles are posted on . Neoadjuvant combination immunotherapy regimens produced higher pathologic response rates than monotherapy in ...

The FDA has started a priority review of MSD's Keytruda as neoadjuvant and adjuvant treatment of locally advanced head and neck squamous cell carcinoma (HNSCC), with a decision due by 23rd June.